Partner News

The findings are clear: disease burden in prisons is extraordinarily high, and without addressing health disparities in carceral settings, global efforts to eliminate HIV, viral hepatitis, and TB will continue to fall short. More

New global data show limited progress toward WHO’s 2030 hepatitis C elimination goals, highlighting disparities in diagnosis and treatment access. More

The Global Prisons Infectious Diseases Network is a newly created organisation dedicated to addressing infectious diseases in custodial settings worldwide. More

Two reports from the Coalition for Global Hepatitis Elimination offer the most comprehensive assessment to date. More

Harm reduction has long been a cornerstone of European public health, being instrumental for the wellbeing of PWUD. However, in the last few years, the financial sustainability of many harm reduction initiatives has been under serious threat. More

Although progress has been made towards the SDG target 3.3 to end the epidemics of HIV, TB, and combatting viral hepatitis B and C and STIs by 2030, EU/EEA is off track for many of the targets. More

International health organisations are struggling to respond to an alarming epidemic of hepatitis C in Rohingya refugees in Cox’s Bazar, Bangladesh. More

Thanks to Drugreporter, selected sessions were available to watch via streaming during the 6th European Harm Reduction Conference (EHRC2024), and their recordings can now be accessed online. More

INHSU 2024 heard from global experts on innovative strategies to eliminate hepatitis C, including groundbreaking approaches to testing, treatment, and data collection. More

The hepatitis C virus remains one of the deadliest infectious diseases, despite the existence of an effective eight-to-twelve week cure. Access to direct acting antivirals must be urgently expanded to save lives. More